Healthcare provider profile · identity verified

Dane A Olsen

Family Practice · MILWAUKEE, WI · NPI 1386178804

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	543	144
Amlodipine Besylate	Amlodipine Besylate	262	76
Gabapentin	Gabapentin	206	52
Lisinopril	Lisinopril	195	48
Losartan Potassium	Losartan Potassium	191	54
Metoprolol Succinate	Metoprolol Succinate	169	41
Metformin Hcl	Metformin Hcl	157	39
Albuterol Sulfate Hfa	Albuterol Sulfate	144	47
Omeprazole	Omeprazole	139	40
Levothyroxine Sodium	Levothyroxine Sodium	128	29
Tamsulosin Hcl	Tamsulosin Hcl	122	30
Carvedilol	Carvedilol	111	27
Furosemide	Furosemide	109	27
Metformin Hcl Er	Metformin Hcl	105	31
Rosuvastatin Calcium	Rosuvastatin Calcium	99	26
Chlorthalidone	Chlorthalidone	98	22
Allopurinol	Allopurinol	95	18
Eliquis	Apixaban	93	20
Famotidine	Famotidine	93	24
Jardiance	Empagliflozin	93	21
Pantoprazole Sodium	Pantoprazole Sodium	83	22
Duloxetine Hcl	Duloxetine Hcl	80	14
Fluticasone Propionate	Fluticasone Propionate	79	34
Clopidogrel	Clopidogrel Bisulfate	78	18
Trazodone Hcl	Trazodone Hcl	72	21
Hydrochlorothiazide	Hydrochlorothiazide	63	21
Triamcinolone Acetonide	Triamcinolone Acetonide	61	22
Simvastatin	Simvastatin	60	12
Zolpidem Tartrate	Zolpidem Tartrate	60	13
Tizanidine Hcl	Tizanidine Hcl	56	21
Montelukast Sodium	Montelukast Sodium	54	15
Ozempic	Semaglutide	50	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	16
Potassium Chloride	Potassium Chloride	48	15
Sertraline Hcl	Sertraline Hcl	48	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	42	13
Ibuprofen	Ibuprofen	39	15
Warfarin Sodium	Warfarin Sodium	39	suppressed
Rybelsus	Semaglutide	37	suppressed
Alprazolam	Alprazolam	36	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	35	suppressed
Pravastatin Sodium	Pravastatin Sodium	35	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	34	suppressed
Finasteride	Finasteride	34	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	14
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	11
Clonazepam	Clonazepam	31	suppressed
Spironolactone	Spironolactone	31	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Clonidine Hcl	Clonidine Hcl	29	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	28	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	28	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	12
Lidocaine	Lidocaine	26	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Ibu	Ibuprofen	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Symbicort	Budesonide/Formoterol Fumarate	25	suppressed
Lovastatin	Lovastatin	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Dexlansoprazole Dr	Dexlansoprazole	23	suppressed
Varenicline Tartrate	Varenicline Tartrate	21	11
Isosorbide Dinitrate	Isosorbide Dinitrate	19	suppressed
Meloxicam	Meloxicam	19	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Bumetanide	Bumetanide	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Tramadol Hcl	Tramadol Hcl	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Topiramate	Topiramate	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Dofetilide	Dofetilide	16	suppressed
Nystatin	Nystatin	16	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	16	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Naproxen	Naproxen	15	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Insulin Aspart Flexpen	Insulin Aspart	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	13	suppressed
Colchicine	Colchicine	13	suppressed
Fluconazole	Fluconazole	13	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Glipizide	Glipizide	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	13	suppressed
Brilinta	Ticagrelor	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Unifine Pentips	Pen Needle, Diabetic	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error